Filing Details

Accession Number:
0001225208-14-011383
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-30 16:06:23
Reporting Period:
2014-04-29
Filing Date:
2014-04-30
Accepted Time:
2014-04-30 16:06:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385187 Covidien Plc COV Surgical & Medical Instruments & Apparatus (3841) 980624794
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1572883 Douglas Brian King C/O Covidien
15 Hampshire Street
Mansfield MA 02048
Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-04-29 8,550 $52.53 45,723 No 4 M Direct
Ordinary Shares Acquisiton 2014-04-29 7,019 $43.44 52,742 No 4 M Direct
Ordinary Shares Disposition 2014-04-29 15,569 $70.11 37,173 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2014-04-29 7,019 $0.00 7,019 $43.44
Ordinary Shares Stock Option (Right to Buy) Disposition 2014-04-29 8,550 $0.00 8,550 $52.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-11-30 No 4 M Direct
25,650 2022-12-02 No 4 M Direct
Footnotes
  1. Includes 3 shares acquired in connection with the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
  2. The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $70.10 to $70.121. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
  3. Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
  4. Options became exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.
  5. Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.